Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 22 results for "cadila healthcare click"

Accumulate Cadila Healthcare; target of Rs 1480: KRChoksey

KRChoksey's report on Cadila Healthcare "Net sales grew by 21.5% YoY to Rs. 2064 crs driven by improved traction in US business. However domestic business showed subdued growth. EBIDTA excluding forex impact grew by 61.5% YoY to Rs.421 crs & ... Moneycontrol.com, 2 weeks ago

Cadila Healthcar - Zydus receives tentative approval for Gli...

The page you are looking for might have been removed, had its name changed, or is temporarily unavailable. Please try the following: Make sure that the Web site address displayed in the address bar of your browser is spelled and formatted ...
 SBICAP Securities2 months ago Zydus receives tentative approval for Glipizide ER tablets  Moneycontrol.com2 months ago

Supernus Files Trokendi XR Patent Infringement Lawsuit - Analyst Blog

Supernus Pharmaceuticals, Inc. ( SUPN ) has filed a patent infringement lawsuit against Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited accusing them of infringement of three patents covering Supernus antiepileptic drug, Trokendi XR. ...
 Zacks.com4 days ago
Seeking Alpha

Gilead: Rising Net Income, Zero Debt And Strong R&D Pipeline

Summary Sovaldi carries Gilead to a blowout quarter with net income up 246%. Gilead Sciences board of directors approved a $5 billion share repurchase program on May 7, 2014. Rich R&D pipeline of 27 new drugs. Gilead Sciences, Inc. (NASDAQ: ...
 Seeking Alpha1 week ago

HDFC Mutual Fund buys telecom, pharma; drops banks

Gammon Infrastructure, Bharti Airtel and Idea Cellular were the top buys, while Gujarat State Fertilizers, Rural Electrification Corpn. and Jaiprakash Associates were the top sells by the fund. The study of HDFC Mutual Fund for the quarter of ...
 Moneycontrol.com2 weeks ago

IDFC, Indian Hotels, Crompton Greaves top buys: Reliance MF

IDFC, Indian Hotels Company and Crompton Greaves were the top buys, while Indiabulls Housing Finance, South Indian Bank and Coal India were the top sells by the fund. The study of Reliance Mutual Fund for the quarter of July-September 2014 shows ...
 Moneycontrol.com3 weeks ago

Haemophilus Infections Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

(ReleaseWire Via Acquire Media NewsEdge) Transparency Market Research (http://www.transparencymarketresearch.com) includes new market research report "Haemophilus Infections Market" to its huge collection of research reports.Albany, NY -- ...
 TMC Net4 weeks ago Report Published: "OTC Medications in India (2014) - Market Sizes"  TMC Net1 month ago Anti-Obesity Prescription Market: Global Industry Analysis and Forecast to 2020  TMC Net1 month ago Global Generic Drugs Market 2014-2018  Pharmacy Choice2 months ago

Ketorolac Tromethamine Injection by Sagent Pharmaceuticals Recalled: AttorneyOne Monitors and Keeps Consumers Informed

On October 6, the FDA announced that three lots of Ketorolac Tromethamine Injection, USP, 30mg/mL single-dose vials, distributed by Sagent, are recalled due to incorrect labeling. In light of this news, AttorneyOne, a recognized authority on law, ...
 Red Orbit1 month ago

Gilead Sciences enters deals with seven drugmakers for Sovaldi generics

Gilead Sciences on Monday announced non-exclusive licensing agreements allowing seven drugmakers, including Cipla, Mylan and Ranbaxy, to manufacture the hepatitis C therapy Sovaldi (sofosbuvir) for distribution in 91 developing countries. Gregg H.
 FirstWord Pharma1 month ago Gilead Gives Seven Generic Firms Sovaldi Licenses for Developing World  FDA News2 months ago Gilead (GILD) Slips on Generic Sovaldi Licensing Deals - Analyst Blog  Zacks.com2 months ago

Pharma cost not to be impacted by NPPA's curb on anti-infective drugs

Following the move of the National Pharmaceutical Pricing Authority to cap the selling price of 43 drug formulations used to treat infections and gastro-intestinal disorders and few vaccines, commonly used antibiotic drugs such as ciprofloxacin, ...
 FirstWord Pharma2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cadila healthcare click
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less